A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events (DEVOTE)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Novo Nordisk A/S

ClinicalTrials.gov Identifier:

NCT01959529

First received: October 8, 2013

Last updated: February 22, 2017

Last verified: February 2017

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 16, 2016
Primary Completion Date:	October 16, 2016 (Final data collection date for primary outcome measure)

Publications: